Anal Papanicolaou Smear in Women with Abnormal Cytology: a Thai Hospital Experience

  • Published : 2015.03.04


Background: Anal intraepithelial lesions (AIL) are likely to represent a precursor for anal cancer. Women infected with human immunodeficiency virus (HIV) may be at higher risk of anal cancer but a screening program for AIL still is not routinely recommended. We here studied the relationship of dysplastic cells from cervical and anal cytology in HIV-infected women. Materials and Methods: This prospective study was conducted in Prapokklao Hospital, Thailand during 2013-2014. Five hundred and ninety nine HIV-infected women were recruited. Participants who had cytological reports of equally or over "abnormal squamous/glandular cells of undetermined significance" (ASC-US) were classified as abnormal cervical or anal cytology. Descriptive statistics and logistic regression analysis were used to evaluate correlations between groups. Results: HIV-infected women with abnormal cervical cytology had 3.8 times more risk (adjusted odd ratio 3.846, 95% confidence interval 1.247-11.862, p-value. 019) for abnormal anal cytology. The major problem of the anal Pap test in this study was the inadequacy of the collected specimens for evaluation (34.4%, 206/599). Sensitivity, specificity, positive predictive value, negative predictive value and accuracy of cervical and anal Pap tests were 93.9/12.0, 87.3/96.9, 39.7/21.4, 99.4/94.1 and 88.1/91.4 percent, respectively. Conclusions: Abnormal cervical cytology in HIV-infected women indicates elevated risk for abnormal anal cytology. The sensitivity of the anal Pap test for detection of AIL 2/3 in HIV-infected women was quite low while specificity was excellent. Inadequacy of specimen collection for evaluation was a major limitation. Improvement of sample collection is recommended for future investigations.


Supported by : Institute of Prapokklao Hospital


  1. Afshar RM, Mollaie HR, Fazlalipour M, et al (2013). Prevalence and type distribution of human papillomavirus infection using the INNo-Lipa assay, Kerman, Southeast Iran. Asian Pac J Cancer Prev, 14, 5287-91.
  2. American Cancer Society (2014). Anal cancer. Causes, risk factors, and prevention topics. Atlanta, Ga: Am Cancer Soc.
  3. Baranoski AS, Tandon R, Weinberg et al (2012). Risk factors for abnormal anal cytology over time in HIV-infected women. AM J Obstet Gynecol, 207, 107.
  4. Bertisch B, Franceschi S, Lise M, et al (2013). Risk factors for anal cancer in persons infected with HIV: a nested case-control study in the Swiss HIV Cohort Study. Am J Epidemiol, 178, 877-84.
  5. Centers for Disease Control and Prevention (2014). HPVAssociated Vulva Cancer Rates by Race and Ethnicity. Retrieved November 9.
  6. Chaturvedi AK, Madeleine MM, Biggar RJ, et al (2009). Risk of human papillomavirus-associated cancers among persons with AIDS. J Natl Cancer Inst, 101, 1120-30.
  7. Chaves EBM, Folgierini H, Capp E, et al (2012). Prevalence of abnormal anal cytology in women infected with HIV. J Med Virol, 84, 1335-9.
  8. Conley L, Bush T, Darragh TM, et al (2010). Factors associated with prevalent abnormal anal cytology in a large cohort of HIV-infected adults in the United States. J Infect Dis, 202, 1567-76.
  9. Etienney I, Vuong S, Daniel F, et al (2008). Prevalence of anal cytologic abnormalities in a French referral population: a prospective study with special emphasis on HIV, HPV, and smoking. Dis Colon Rectum, 51, 67-72.
  10. Ferrari A, Narasimhan K, Rahman I, et al (2008). Anal pap test in high-risk patients: a poor screening tool. Southern Med J, 101, 1185-6.
  11. Gaisa M, Sigel K, Hand J, Goldstone S (2014). High rates of anal dysplasia in HIV-infected men who have sex with men, women, and heterosexual men. AIDS, 28, 215-22.
  12. Ghosh I, Ghosh P, Bharti AC, et al (2012). Prevalence of human papillomavirus and co-existent sexually transmitted infections among female sex workers, men having sex with men and injectable drug abusers from eastern India. Asian Pac J Cancer Prev, 13, 799-802.
  13. Kojic EM, Cu-Uvin S, Conley L, et al (2011). Human papillomavirus infection and cytologic abnormalities of the anus and cervix among HIV-infected women in the study to understand the natural history of HIV/AIDS in the era of effective therapy (the SUN study). Sex Transm Dis, 38, 253-9.
  14. Lammé J, Pattaratornkosohn T, Mercado-Abadie J, et al (2014). Concurrent anal human papillomavirus and abnormal anal cytology in women with known cervical dysplasia. Obstet Gynecol, 124, 242-8.
  15. MMWR Recommendations and Reports (2009). Guidelines for prevention and treatment of opportunistic infections in HIV-Infected adults and adolescents /recommendations from CDC, the national institutes of health, and the HIV medicine association of the infectious diseases society of America. MMWR recommendations and reports. 58.
  16. Mullins TL, Wilson C, Rudy BJ, et al (2013). Incident anal human papillomavirus and human papillomavirusrelated sequelae in HIV-infected versus HIV-uninfected adolescents in the United States. Sex Trans Dis, 40, 715-20.
  17. Palefsky JM, Holly EA, Ralston ML, et al (1998). Anal squamous intraepithelial lesions in HIV-postive and HIV-negative homosexual and bisexual men: prevalence and risk factors. J Acquir Immune Defic Syndr Hum Retrovirol, 17, 320-6.
  18. Piketty C, Selinger-Leneman H, Bouvier AM, et al (2012). Incidence of HIV-related anal cancer remains increased despite long-term combined antiretroviral treatment: results from the French Hospital Database on HIV. J Clin Oncol, 30, 4360-6.
  19. Pittyanont S, Yuthavisuthi P, Sananpanichkul P, et al (2014). Prevalence of abnormal anal cytology in HIV-infected women: a hospital base study. Asian Pac J Cancer Prev, 15, 6405-9.
  20. Siegel R, Naishadham D, Jemal A (2012). Cancer statistics, 2012. CA Cancer J Clin, 62, 10-29.
  21. Solomon D, Nayar R (2004). The Bethesda system for reporting cervical cytology: definitions, criteria, and explanatory notes. 2nd edition. New York: Springer-Verlag New York.
  22. Suwannarurk K, Tapanadechopol P, Pattaraarchachai J, et al (2009). Hospital-based prevalence and sensitivity of highrisk human papillomavirus in Thai urban population. Cancer Epidemiol, 33, 56-60.
  23. Thai National Aids Committee (2014). Thailand AIDS response progress report. national AIDS management center.
  24. Zhang HY, Tiggelaar SM, Sahasrabuddhe VV, et al (2012). HPV prevalence and cervical intraepithelial neoplasia among HIV infected women in Yunnan Province, China: a pilot study. Asian Pac J Cancer Prev, 13, 91-6.

Cited by

  1. Results of the Womenʼs Self-Performed Anal Pap Trial in Human Immunodeficiency Virus–Infected Women vol.43, pp.7, 2016,